These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7911030)

  • 1. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
    Baird PN; Pritchard J; Cowell JK
    Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
    Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
    Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
    Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
    Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
    Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
    Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
    Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
    Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.